Literature DB >> 15809760

Angiogenesis in breast cancer: how should we measure this? (Review).

M J K Pollitt1, A M Hanby, K Horgan, C E Murphy, P F Jones, V Speirs.   

Abstract

Despite the established importance of angiogenesis in the pathogenesis of solid tumours, there is still no consensus on how this is best measured or which method is the most appropriate in the determination of prognosis. Here we review the pros and cons of current methods of assessing angiogenesis, both clinical and in the laboratory, and discuss with respect to breast cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15809760     DOI: 10.3892/or.13.5.931

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.

Authors:  Alexander Yaw Debrah; Sabine Mand; Sabine Specht; Yeboah Marfo-Debrekyei; Linda Batsa; Kenneth Pfarr; John Larbi; Bernard Lawson; Mark Taylor; Ohene Adjei; Achim Hoerauf
Journal:  PLoS Pathog       Date:  2006-09       Impact factor: 6.823

2.  Impact of breast cancer surgery on angiogenesis circulating biomarkers: a prospective longitudinal study.

Authors:  Georgios K Georgiou; Maria Igglezou; Ioannis Sainis; Katerina Vareli; Haralampos Batsis; Evangelos Briasoulis; Michalis Fatouros
Journal:  World J Surg Oncol       Date:  2013-08-27       Impact factor: 2.754

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.